Tema Oncology ETF (NASDAQ:CANC) Stock Price Up 0.4% – Here’s What Happened

Tema Oncology ETF (NASDAQ:CANC) shares shot up 0.4% during mid-day trading on Thursday . The company traded as high as $36.28 and last traded at $36.09. 116,268 shares were traded during mid-day trading, an increase of 86% from the average session volume of 62,393 shares. The stock had previously closed at $35.93.

Tema Oncology ETF Trading Up 0.4%

The firm has a market cap of $142.92 million, a price-to-earnings ratio of 20.39 and a beta of 1.00. The firm’s 50-day moving average is $35.49 and its 200-day moving average is $30.84.

Tema Oncology ETF Dividend Announcement

The firm also recently disclosed an annual dividend, which was paid on Thursday, December 11th. Stockholders of record on Wednesday, December 10th were issued a dividend of $0.0196 per share. This represents a dividend yield of 6.0%. The ex-dividend date was Wednesday, December 10th.

Hedge Funds Weigh In On Tema Oncology ETF

Large investors have recently added to or reduced their stakes in the business. Thrivent Financial for Lutherans boosted its stake in Tema Oncology ETF by 658.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 957,475 shares of the company’s stock valued at $23,673,000 after purchasing an additional 831,281 shares during the last quarter. Flow Traders U.S. LLC bought a new position in shares of Tema Oncology ETF in the third quarter valued at approximately $630,000. Finally, Jane Street Group LLC boosted its position in shares of Tema Oncology ETF by 59.7% during the second quarter. Jane Street Group LLC now owns 14,104 shares of the company’s stock valued at $349,000 after buying an additional 5,275 shares during the last quarter.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.